3 Things for Primary Care to Remember About Physical Medicine and Rehabilitation
Scott Laker, MD, vice president of the AAPM&R, offers 3 thoughts on what primary care clinicians should think of when they think about PM&R.
Daily Dose: Anxiety in America
Your daily dose of clinical news you may have missed.
FDA Approves Novel Drug for the Treatment of Hot Flashes Caused by Menopause
Fezolinetant is the first NK3 receptor antagonist approved by the FDA for treatment of moderate-to-severe vasomotor symptoms due to menopause.
Friday's 5 Quotes for Primary Care 5-12-2023
USPSTF says start mammograms 10 years earlier, OTC contraceptive coming soon, another antiobesity drug in the wings, and 2 more weekly updates of note.
FDA Approves Brexpiprazole for Agitation Associated with Alzheimer Dementia
Brexpiprazole, an atypical antipsychotic, is the first and only medication approved to treat AD-associated agitation, reported in almost half of people with the disease.
Study Finds COVID-19 Neutralizing Antibody Response Differs by Vaccine Type
Neutralizing antibodies were lowest among Janssen volunteers at 1 month post-vaccination but at 6 months afterward, the picture was much different.
Drug Use in America: Which States are Problem Areas?
Which state has the highest percentage of teenage drug users? Or the fewest opioid prescriptions? Answers from a new report, here.
New Report Shows Where Drug Abuse is Most, Least Pronounced in the US
Find out where drug abuse is most pronounced and which states are at greatest risk for associated problems, here.
Daily Dose: Testicular Volume in Boys with Obesity
Medication Can't Do It All, Says Obesity and Weight Management Expert
Dr Caroline Apovian reminds primary care clinicians who care for patients with obesity that diet and lifestyle counseling are essential for maximum results.
DEA Extends Telehealth Prescribing Rule for Controlled Substances
The telehealth practice adopted in March 2020 at the start of the COVID public health emergency will be extended until November 11, 2023.
Primary Care and Physiatry: Complementary Tools for Full Recovery from Injury
The partnership between primary care and PM&R is a tool in each specialty's tool box, with the patient's return to full function the shared goal.
Boys with Overweight/Obesity Have Lower Testicular Volume, According to New Study
Participants with overweight or obesity had lower testicular volume than their healthy peers, putting them at risk for infertility later in adulthood.
Daily Dose: Sex‐Specific Reproductive Factors Augment CVD Risk in Women
Oral Contraceptive Gets Unanimous Recommendation for OTC Use from FDA Advisory Panel
Opill, a progestin-only oral contraceptive, if approved by the FDA, would be the first an only form of birth control in the US available without a physician's prescription.
Investigational Antiobesity Drug from Boehringer Ingelheim Meets Primary Endpoint in Phase 2 Trial
The dual GIP/GLP-1 receptor agonist was associated with a nearly 15% reduction in body weight in adults with overweight/obesity and without type 2 diabetes.
Improved Diabetes and Kidney Function Control With KidneyIntelX
Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.
Referral of High- and Low-Risk Groups in DKD
Aida Vega, MD, and Fernando Carnavali, MD, discuss the KidneyIntelX study and the rates of referrals of high-risk DKD patients to specialist care.
KidneyIntelX in DKD Study Population Characteristics
Aida Vega, MD, and Fernando Carnavali, MD, review the population characteristics of a study involving the use of KidneyIntelX in DKD.
Denosumab Superior to Alendronate for Reduction of Postmenopausal Fracture Risk in Real-world Study
Denosumab reduced RR of fracture vs alendronate across fracture types, eg, by 36% for hip fracture, by 43% for nonvertebral fractures, and by 30% for vertebral fractures.
